We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Aurinia Pharmaceuticals Inc | NASDAQ:AUPH | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.025 | -0.48% | 5.215 | 5.21 | 5.22 | 5.285 | 5.13 | 5.26 | 428,240 | 20:12:46 |
Dated: November 7, 2019
|
|
|
|
|
|
|
|
|
|
Aurinia Pharmaceuticals Inc.
|
|
|
|
|
|
By:
|
/s/ Peter S. Greenleaf
|
|
|
Name: Peter S. Greenleaf
|
|
|
Title: Chief Executive Officer
|
Exhibit
|
Description of Exhibit
|
|
99.1
|
News Release - AURINIA COMPLETES VOCLOSPORIN DRUG-DRUG
INTERACTION STUDY DEMONSTRATING NO CLINICALLY SIGNIFICANT INTERACTION WITH MYCOPHENOLATE MOFETIL
|
1 Year Aurinia Pharmaceuticals Chart |
1 Month Aurinia Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions